Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides.
Greco I, Molchanova N, Holmedal E, Jenssen H, Hummel BD, Watts JL, Håkansson J, Hansen PR, Svenson J. · 2020
Read Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides. by Greco I, Molchanova N, Holmedal E, Jenssen H, Hummel BD, Watts JL, Håkansson J, Hansen PR, Svenson J. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7414031.txt.
Description
Greco and co-authors test the toxicity of synthetic antimicrobial peptides in Scientific Reports. Such peptides promise new antibiotics, but odd toxicity models slow their path to the clinic. The team studied a library of 24 peptides aimed at veterinary pathogens, in cells and in rats.
Red blood cell damage varied by species, worst for dog cells and mildest for cattle cells, with human cells in between. Against three human cell lines the peptides looked more stable still, and therapeutic indexes of 50 to 500 suggested real selectivity for bacteria over body cells. Three peptides dosed into rats at multiples of their working dose caused no systemic toxicity. The assays, the authors stress, do not line up neatly, which is itself the warning.
Catalog record
| CREATOR | Greco I, Molchanova N, Holmedal E, Jenssen H, Hummel BD, Watts JL, Håkansson J, Hansen PR, Svenson J. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |